A blood test, called an AMH (Anti-Müllerian Hormone) test, is used to test for women's ovarian reserve (that is, the number of eggs remaining in their ovaries). AMH is manufactured by the tiny follicles found in the ovary, and it is an excellent indicator of fertility potential. The test is frequently used for evaluating fertility, evaluating infertility, diagnosing polycystic ovary syndrome (PCOS), and to help plan a treatment for assisted reproduction like IVF (In Vitro Fertilization).

In Molecular Diagnostics and Therapy, we have a pathology lab and an NABL & NABH-accredited diagnostic centre for providing AMH tests with the latest immunity assay technology. With our experienced laboratory professionals, we can ensure timely reporting of reliability in the results needed for the assessment of fertility and management of fertility health.

About AMH – Anti-Müllerian Hormone

The production of AMH by the developing ovarian follicles corresponds to the number of eggs remaining. Though AMH is relatively constant across the menstrual cycle, it can be measured at any point if medical advice does not suggest otherwise. The AMH test is typically ordered for women who are planning, experiencing infertility, considering freezing their eggs, or undergoing fertility treatment.

What is an AMH – Anti-Müllerian Hormone Test?

The Anti-Müllerian Hormone test is used to test blood levels of the AMH protein. The findings can help physicians determine how well the ovaries are responding and to determine the doctor's prognosis when considering fertility treatments.

AMH is valuable for providing information on the quantity of eggs but does not measure their quality or indicate fertility, and should always be coupled with age, the clinical history, ultrasound results, and other hormone tests.

Common Reasons for an AMH – Anti-Müllerian Hormone Test

Your doctor should recommend this test to:

• Evaluate ovarian reserve
• Assess female fertility potential
• Investigate infertility
• Diagnose or support evaluation of polycystic ovary syndrome (PCOS)
• Predict response to IVF or ovarian stimulation
• Plan fertility preservation before cancer treatment
• Evaluate premature ovarian insufficiency (early menopause)
• Monitor ovarian function after ovarian surgery
• Assess reproductive health before assisted reproductive techniques
• Support fertility counseling

Conditions Evaluated

The AMH test helps evaluate:

• Ovarian reserve
• Female infertility
• Polycystic ovary syndrome (PCOS)
• Premature ovarian insufficiency
• Diminished ovarian reserve
• Menstrual irregularities
• Response to IVF treatment
• Fertility preservation planning
• Ovarian function after surgery
• Reproductive endocrine disorders

Benefits of AMH – Anti-Müllerian Hormone Test

• Reliable assessment of ovarian reserve
• Can be performed on most days of the menstrual cycle
• Helps guide fertility treatment planning
• Assists in predicting response to ovarian stimulation
• Supports early evaluation of reduced ovarian reserve
• Simple and minimally invasive blood test
• Useful in diagnosing and monitoring PCOS

Risks and Limitations

Safety

• Safe and routine blood test with minimal risk.
• Mild pain, bruising, or slight bleeding at the blood collection site should occur temporarily.

Limitations

• AMH measures egg quantity, not egg quality.
• A normal AMH level does not guarantee pregnancy, and a low AMH level does not necessarily mean pregnancy is impossible.
• Results should always be interpreted alongside age, ultrasound findings (Antral Follicle Count), FSH, LH, Estradiol, and clinical evaluation.
• AMH levels should vary depending on laboratory methods and certain medical conditions.

Conclusion

One of the tests used in determining ovarian reserve and reproductive health is called the Anti-Müllerian Hormone (AMH). It is very helpful in fertility evaluation, evaluation of infertility, planning for IVF, and diagnosis of conditions like PCOS and premature ovarian insufficiency. Accurate AMH Testing, Expert Labwork, and Quick Reporting for Informed Fertility Decisions are found at Molecular Diagnostics and Therapy.